설명

According to NIH, autoimmune disorders are conditions in which the body’s immune system mistakenly attacks and destroys healthy tissues of the body by perceiving them as foreign bodies. The majority of autoimmune disorders cause inflammation of affected parts of the body. The most commonly occurring autoimmune disorder include psoriasis, systemic lupus erythematosus, and rheumatoid arthritis, 무엇보다도. The global autoimmune disorder drugs market in terms of revenue is set to grow by US$ 40 10억 동안 2021-2027, 연평균 성장률로 성장 (CAGR) ~의 9.8% 예측 기간 동안, 데이터 및 분석 회사 StrategyHelix에 따르면. Growth in the geriatric population, increasing prevalence of autoimmune disorders, the rise in technological advancements for the diagnosis of autoimmune diseases are expected to boost the market growth in the coming years.

이 보고서는 기간 동안 최신 시장 규모 데이터를 제공합니다. 2017-2020 그리고 예측 2027 covering key market aspects like sales value for autoimmune disorder drugs. The global autoimmune disorder drugs market is segmented on the basis of type, indication, 지역. 유형별, it is categorized into nonsteroidal anti-inflammatory drugs (NSAIDs), and Immunosuppressant drugs. The NSAIDs segment held the largest market share in 2020. By indication, the autoimmune disorder drugs market is divided into rheumatoid arthritis, systemic lupus erythematosus, psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, type 1 diabetes, 다른 사람. The rheumatoid arthritis segment accounted for the largest market share in 2020. 지역에 따라, the autoimmune disorder drugs market is divided into North America, 아시아 태평양, 유럽, 및 기타 국가 (열).

The report has profiled some of the key players of the market such as AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Bristol Myers Squibb (BMS), 존슨 & 존슨, Mylan N.V., Novartis AG, Pfizer Inc., Roche Holding AG, Vertex Pharmaceuticals Inc..

이 보고서는 이 업계에서 활동하는 회사 및 조직에 매우 귀중한 리소스입니다.. It provides a cohesive picture of the autoimmune disorder drugs market to help drive informed decision making for industry executives, 정책 입안자, 학생, 및 분석가.

보고 범위

유형: nonsteroidal anti-inflammatory drugs (NSAIDs), and Immunosuppressant drugs
Indication: rheumatoid arthritis, systemic lupus erythematosus, psoriasis/psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, type 1 diabetes, 다른 사람
지역: 북아메리카, 아시아 태평양, 유럽, 및 기타 국가 (열)
고려한 연도: 이 보고서는 기간을 다룹니다 2017 에게 2027

이해관계자를 위한 주요 이점

Get a comprehensive picture of the global autoimmune disorder drugs market
성장 분야 및 투자 동향 파악
Understand what the future of the global autoimmune disorder drugs market looks like
경쟁 구도 및 기회의 창 식별

목차

1. 시장 정의
2. 연구 방법론
3. 시장 데이터 & 시야
3.1 시장 가치
3.2 시장 가치 예측
4. Autoimmune Disorder Drugs Market by Type
4.1 Nonsteroidal Anti-Inflammatory Drugs (Nsaids)
4.2 Immunosuppressant Drugs
5. Autoimmune Disorder Drugs Market by Indication
5.1 Rheumatoid Arthritis
5.2 Systemic Lupus Erythematosus
5.3 Psoriasis/Psoriatic Arthritis
5.4 Multiple Sclerosis
5.5 Inflammatory Bowel Disease
5.6 유형 1 당뇨병
5.7 기타
6. Autoimmune Disorder Drugs Market by Region
6.1 북아메리카
6.2 아시아 태평양
6.3 유럽
6.4 나머지 세계 (열)
7. 회사 프로필
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 AstraZeneca plc
7.4 Bayer AG
7.5 Bristol Myers Squibb (BMS)
7.6 존슨 & 존슨
7.7 Mylan N.V.
7.8 Novartis AG
7.9 Pfizer Inc.
7.10 Roche Holding AG
7.11 Vertex Pharmaceuticals, 주식회사.
8. 부록
8.1 스트래티지헬릭스 소개
8.2 부인 성명